When worry and fear interfere with daily life, an anxiety disorder may be the cause. These disorders are the most common of all mental illnesses, impacting about 18% of adults in the United States. While cognitive/behavioral interventions may be effective alone, frequently psychopharmacology provides necessary or even preferred relief. Chronic stress or trauma, medical conditions, or genetics contribute to alterations in stress hormones and other neurochemicals. Understanding these as well as other neurobiological factors is essential to safe and efficacious treatment. This one day workshop provides the latest developments in the neuropharmacology of Anxiety Disorders. Case discussions will demonstrate the nuances of diagnosis, intervention, and recovery.
At the conclusion of this workshop, participants will be able to:
Describe the new developments and differences in the DSM-5 diagnostic categories for Anxiety Disorders.
Discuss the neurobiological contributors to Anxiety Disorders, including generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive compulsive disorder.
Explore choices in psychopharmacologic interventions.
Analyze diagnosis and treatment options in a variety of common case presentations.